# EDGAR Filing Document

**Accession Number:** 0001688126
**File Stem:** 0001641172-25-024368
**Filing Date:** 2025-8
**Character Count:** 126394
**Document Hash:** cbbbe1d095cd2135e334e4869c56f3f2
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001641172-25-024368.hdr.sgml**: 20250815

**ACCESSION NUMBER**: 0001641172-25-024368

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 142

**CONFORMED PERIOD OF REPORT**: 20250630

**FILED AS OF DATE**: 20250815

**DATE AS OF CHANGE**: 20250815

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Crypto Co
- **CENTRAL INDEX KEY:** 0001688126
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-COMPUTER PROCESSING & DATA PREPARATION [7374]
- **ORGANIZATION NAME:** 06 Technology
- **EIN:** 464212405
- **STATE OF INCORPORATION:** NV
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-55726
- **FILM NUMBER:** 251224676

**BUSINESS ADDRESS:**
- **STREET 1:** 23823 MALIBU ROAD
- **STREET 2:** SUITE 50477
- **CITY:** MALIBU
- **STATE:** CA
- **ZIP:** 90265
- **BUSINESS PHONE:** (424) 228-9955

**MAIL ADDRESS:**
- **STREET 1:** 23823 MALIBU ROAD
- **STREET 2:** SUITE 50477
- **CITY:** MALIBU
- **STATE:** CA
- **ZIP:** 90265

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** CROE, INC.
- **DATE OF NAME CHANGE:** 20161020

?xml version='1.0' encoding='ASCII'?

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 10-Q**

☒ **QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

**For the quarterly period ended June 30, 2025**

**OR**

☐ **TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

**For the transition period from __________ to __________**

**Commission File Number: 000-55726**

**THE CRYPTO COMPANY**

(Exact name of registrant as specified in its charter)

---

| | |
|:---|:---|
| **Nevada** | **46-4212105** |
| (State or other jurisdiction of | (I.R.S. Employer |
| incorporation or organization) | Identification No.) |

---

**23823 Malibu Road, # 50477**

**Malibu, California 90265**

(Address of principal executive offices)

**(424) 228-9955**

(Registrant's telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934:

---

| | | |
|:---|:---|:---|
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
| None | N/A | N/A |

---

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period than the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act. (Check one):

---

| | |
|:---|:---|
| Large accelerated filer ☐ | Accelerated filer ☐ |
| Non-accelerated filer ☒ | Smaller reporting company ☒ |
| Emerging growth company ☐ |  |

---

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of August 14, 2025 the issuer had 3,900,220,360 shares of common stock, par value $0.001 per share, outstanding.

**TABLE OF CONTENTS**

---

| | | |
|:---|:---|:---|
|  |  | **Page No.** |
| **PART I FINANCIAL INFORMATION** | **PART I FINANCIAL INFORMATION** |  |
| **Item 1.** | Financial Statements |  |
|  | [Consolidated Balance Sheets as of June 30, 2025 (Unaudited) and December 31, 2024](#sq_001) | 4 |
|  | [Unaudited Consolidated Statements of Operations for the Three and Six Months Ended June 30, 2025 and 2024](#sq_002) | 5 |
|  | [Unaudited Consolidated Statements of Stockholders' Deficit for the Three and Six Months Ended June 30, 2025 and 2024](#sq_003) | 6 |
|  | [Unaudited Consolidated Statements of Cash Flows for the Six Months Ended June 30, 2025 and 2024](#sq_004) | 7 |
|  | [Notes to Unaudited Consolidated Financial Statements](#sq_005) | 8 |
| **Item 2.** | [Management's Discussion and Analysis of Financial Condition and Results of Operations](#a_001) | 25 |
| **Item 3.** | [Quantitative and Qualitative Disclosures About Market Risk](#a_002) | 29 |
| **Item 4.** | [Controls and Procedures](#a_003) | 29 |
| **[PART II OTHER INFORMATION](#a_004)** | **[PART II OTHER INFORMATION](#a_004)** | 30 |
| **Item 1.** | [Legal Proceedings](#a_005) | 30 |
| **Item 1A.** | [Risk Factors](#a_006) | 30 |
| **Item 3.** | [Defaults upon Senior Securities](#a_007) | 30 |
| **Item 4.** | [Mine Safety Disclosures](#a_008) | 30 |
| **Item 5.** | [Other Information](#a_009) | 30 |
| **Item 6.** | [Exhibits](#a_010) | 31 |
| **[SIGNATURES](#a_011)** | **[SIGNATURES](#a_011)** | 32 |

---

**NOTE ABOUT FORWARD-LOOKING STATEMENTS**

This Quarterly Report on Form 10-Q (the "Quarterly Report") contains forward-looking statements. All statements contained in this Quarterly Report other than statements of historical fact, including statements regarding our future results of operations and financial position, our business strategy and plans, and our objectives for future operations, are forward-looking statements. The words "believe," "may," "will," "estimate," "continue," "anticipate," "intend," "expect," and similar expressions are intended to identify forward-looking statements. We have based these forward-looking statements largely on our current expectations and projections about future events and trends that we believe may affect our financial condition, results of operations, business strategy, short- term and long-term business operations, and objectives, and financial needs. These forward-looking statements are subject to a number of risks, uncertainties, and assumptions, including those described in our Annual Report on Form 10-K for the year ended December 31, 2024 (the "2024 Annual Report") as filed with the U.S. Securities and Exchange Commission ("SEC") and in any subsequent filings with the SEC. Moreover, we operate in a very competitive and rapidly changing environment. New risks emerge from time to time. Our management cannot predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements we may make. In light of these risks, uncertainties, and assumptions, the future events, and trends discussed in this Quarterly Report may not occur and actual results could differ materially and adversely from those anticipated or implied in the forward-looking statements.

We undertake no obligation to revise or publicly release the results of any revision to these forward-looking statements, except as required by law. Given these risks and uncertainties, readers are cautioned not to place undue reliance on such forward-looking statements.

Unless expressly indicated or the context requires otherwise, unless expressly indicated or the context requires otherwise, the terms "Crypto," the "Company," "we," "us," and "our" in these consolidated financial statements refer to The Crypto Company and, where appropriate, its wholly-owned subsidiary Blockchain Training Alliance, Inc. ("BTA") and an inactive subsidiary Coin Tracking, LLC ("CoinTracking").

**THE CRYPTO COMPANY**

**CONSOLIDATED BALANCE SHEETS**

---

| | | |
|:---|:---|:---|
|  | June 30, 2025 | December 31, 2024 |
|  | (Unaudited) | |
| **ASSETS** |  |  |
| CURRENT ASSETS |  |  |
| &nbsp;&nbsp;&nbsp;Cash and cash equivalents | $4278 | $1763 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current assets | 4278 | 1763 |
| TOTAL ASSETS | $4278 | $1763 |
| **LIABILITIES AND STOCKHOLDERS' DEFICIT** |  |  |
| CURRENT LIABILITIES |  |  |
| &nbsp;&nbsp;&nbsp;Accounts payable and accrued expenses | $3997563 | $3549339 |
| &nbsp;&nbsp;&nbsp;Other liabilities | 207938 | 207938 |
| &nbsp;&nbsp;&nbsp;Notes payable | 3022074 | 2805253 |
| Convertible debt | 125000 | 125000 |
| &nbsp;&nbsp;&nbsp;Total current liabilities | 7352574 | 6687530 |
| Notes payable - other | 12330 | 12625 |
| TOTAL LIABILITIES | 7364904 | 6700155 |
| STOCKHOLDERS' DEFICIT |  |  |
| &nbsp;&nbsp;&nbsp;Preferred A voting stock, $0.001 par value; 10 shares authorized 10 and -0- shares issued and outstanding, respectively, as of June 30, 2025 and December 31, 2024 |  |  |
| &nbsp;&nbsp;&nbsp;Common stock, $0.001 par value; 19,000,000,000 shares authorized 3,900,220,360 and 3,032,746,878 shares issued and outstanding, respectively, as of June 30, 2025 and December 31, 2024, respectively. | 3900219 | 3032746 |
| &nbsp;&nbsp;&nbsp;Additional paid-in-capital | 43765323 | 43675323 |
| &nbsp;&nbsp;&nbsp;Accumulated deficit | (55026169) | (53406461) |
| TOTAL STOCKHOLDERS' DEFICIT | (7360627) | (6698392) |
| TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT | $4278 | $1763 |

---

The accompanying notes are an integral part of the unaudited consolidated financial statements.

**THE CRYPTO COMPANY**

**CONSOLIDATED STATEMENTS OF OPERATIONS**

**(UNAUDITED)**

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | For the three<br>months ended<br>June 30, 2025 | For the three<br>months ended<br>June 30, 2024 | For the six<br>months ended<br>June 30, 2025 | For the six<br>months ended<br>June 30, 2024 |
|  | | (Restated) | | (Restated) |
| Revenue: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Services | $4230 | $9841 | $7086 | $25647 |
| &nbsp;&nbsp;&nbsp;Cost of services | - | 7733 | - | 9258 |
| &nbsp;&nbsp;&nbsp;Gross margin | 4230 | 2107 | 7086 | 16388 |
| Operating expenses: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;General and administrative expenses | 305454 | 243823 | 625397 | 686653 |
| &nbsp;&nbsp;&nbsp;Share-based compensation | 469674 | 439487 | 628473 | 1706700 |
| &nbsp;&nbsp;&nbsp;Total operating expenses | 775128 | 683310 | 1253871 | 2393353 |
| Operating loss | (770898) | (681203) | (1246785) | (2376965) |
| &nbsp;&nbsp;&nbsp;Other income and (expense) |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Gain on the forgiveness of debt |  |  | 129130 |  |
| &nbsp;&nbsp;&nbsp;Loss on the extinguishment of debt |  |  | (157575) |  |
| &nbsp;&nbsp;&nbsp;Gain on the sale of property |  |  | 10000 |  |
| &nbsp;&nbsp;&nbsp;Interest expense | (237227) | (193192) | (354478) | (393349) |
| Total other (expense) | (237227) | (193192) | (372923) | (393349) |
| Loss before provision for income taxes | (1008125) | (874395) | (1619708) | (2770314) |
| Provision for income taxes | - | - | - | - |
| Net (loss) | $(1008125) | $(874395) | $(1619708) | $(2770314) |
| &nbsp;&nbsp;&nbsp;Net (loss) per share | $(0.00) | $(0.00) | $(0.00) | $(0.00) |
| &nbsp;&nbsp;&nbsp;Weighted average common shares outstanding – basic and diluted | 3485390921 | 1981881172 | 3383682064 | 1442211647 |

---

The accompanying notes are an integral part of the (unaudited) consolidated financial statements.

**THE CRYPTO COMPANY**

**CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT**

**(UNAUDITED)**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | Common stock | Common stock | | | |
|  | Shares | Amount |<br>Paid in<br>capital |<br>Accumulated<br>Deficit | Total<br>Stockholders'<br>Deficit |
| **Balance, December 31, 2023 - Restated** | 565709873 | $565321 | $39932216 | $(45925846) | $&nbsp;&nbsp;&nbsp;&nbsp;(5428309) |
| Additional paid in capital |  |  | 3000 |  | 3000 |
| Common stock issued for note conversion | 505789961 | 505790 | 323919 |  | 829709 |
| Net loss |  |  |  | (1091905) |  |
| **Balance, March 31, 2024 - Restated** | 1071499834 | $1071111 | $40259135 | $(47017751) | $(5687505) |
| Common stock issued for debt conversion | 910431788 | 910432 |  |  | 910432 |
| Stock compensation expense |  |  | 332732 |  | 332732 |
| Debt discount for warrants |  |  | 17998 |  | 17998 |
| Net loss |  |  |  | (874395) | (874395) |
| Balance, June 30, 2024 - Restated | 1981931622 | $1981882 | $40609865 | $(47892146) | $(5300738) |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | Common stock | Common stock | | | |
|  | Shares | Amount | Paid in<br>capital | Accumulated<br>Deficit | Stockholders'<br>Deficit |
| **Balance, December 31, 2024** | 3032746878 | $3032746 | $43675323 | $(53406461) | $&nbsp;&nbsp;&nbsp;&nbsp;(6698392) |
|  | 3008796498 | (867473.25) | (90000.00) | 1619707.43 |  |
| Issuance of common stock for services | 158799643 | 158800 |  |  | 158800 |
| Issuance of warrants for financing fee |  |  | 15000 |  | 15000 |
| Common stock issued for note conversion | 239000000 | 239000 |  |  | 239000 |
| Net loss |  |  |  | (611582) | (611582) |
| Balance, March 31, 2025 | 3430546521 | $3430545 | $43690323 | $(54018042) | $(6897175) |
| Issuance of warrants for financing fee |  |  | 75000 |  | 75000 |
| Issuance of common stock for services | 469673839 | 469674 |  |  | 469674 |
| Net loss |  |  |  | (1008125) | (1008125) |
| Balance, June 30, 2025 | 3900220360 | $3900218 | $43765323 | $(55026167) | $(7360627) |

---

The accompanying notes are an integral part of the unaudited consolidated financial statements.

**THE CRYPTO COMPANY**

**CONSOLIDATED STATEMENTS OF CASH FLOWS**

**(UNAUDITED)**

---

| | | |
|:---|:---|:---|
|  | For the six<br>months ended<br>June 30, 2025 | For the six<br>months ended<br>June 30, 2024 |
| **Cash flows from operating activities:** |  |  |
| Net (loss) | $(1619708) | $(2770314) |
| Adjustments to reconcile net loss to net cash used in operations: |  |  |
| &nbsp;&nbsp;&nbsp;Loss on the extinguishment of debt | 157575 |  |
| &nbsp;&nbsp;&nbsp;Share-based compensation | 628473 | 1706700 |
| &nbsp;&nbsp;&nbsp;Warrants issued for financing fee | 90000 | 17998 |
| &nbsp;&nbsp;&nbsp;Prepaid expenses |  | 17834 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable and accrued expenses | 448223 | 426043 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash (used in) operating activities | (295436) | (601739) |
| **Cash flows from financing activities:** |  |  |
| &nbsp;&nbsp;&nbsp;Payment of notes payable | (385) |  |
| &nbsp;&nbsp;&nbsp;Proceeds from issuance of notes payable | 298336 | 560155 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash provided by financing activities | 297951 | 560155 |
| Net increase (decrease) in cash and cash equivalents | 2515 | (41584) |
| Cash and cash equivalents at the beginning of the period | 1763 | 72970 |
| Cash and cash equivalents at the end of the period | $4278 | $31386 |
| SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION: |  |  |
| Common stock issued for convertible debt | $239000 | $366511 |

---

The accompanying notes are an integral part of the unaudited consolidated financial statements.

**THE CRYPTO COMPANY**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

**NOTE 1 – THE COMPANY**

The Crypto Company was incorporated in the State of Nevada on March 9, 2017. The Company is engaged in the business of providing consulting services and education for distributed ledger technologies ("blockchain"), for the building of technological infrastructure and enterprise blockchain technology solutions. The Company currently generates revenues and incurs expenses solely through these consulting operations.

Unless expressly indicated or the context requires otherwise, the terms "Crypto," the "Company," "we," "us," and "our" in these consolidated financial statements refer to The Crypto Company and, where appropriate, its wholly-owned subsidiary Technology Convergence Company ("TechCC") formerly Blockchain Training Alliance, Inc. ("BTA") and an inactive subsidiary Coin Tracking, LLC ("CoinTracking").

The Company entered into a Stock Purchase Agreement (the "SPA") effective as of March 24, 2021 with BTA and its stockholders. On April 8, 2021, the Company completed the acquisition of all of the issued and outstanding stock of BTA and BTA became a wholly-owned subsidiary of the Company. As a result of this acquisition, the operations of BTA became consolidated with Company operations on April 8, 2021.

TechCC is a blockchain training company and service provider that provides training and educational courses focused on blockchain technology and education as to the general understanding of blockchain to corporate and individual clients.

During the six months ended June 30, 2025, and years ended December 31, 2024 and 2023, the Company generated revenues and incurred expenses primarily through the business of providing consulting services and education for distributed ledger technologies, for the building of technological infrastructure and enterprise blockchain technology solutions, both of which have ceased operations as of the date of this Annual Report.

**NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES**

**<u>Going Concern</u>**

The Company's consolidated financial statements are prepared using the accrual method of accounting in accordance with United States ("U.S.") generally accepted accounting principles ("GAAP") and have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities in the normal course of business. The Company has incurred significant losses and experienced negative cash flows since inception. As of June 30, 2025, the Company had cash of $4,278. In addition, the Company's net loss was $1,619,708 for the six months ended June 30, 2025 and the Company's had a working capital deficit of $7,348,296. As of June 30, 2025 the accumulated deficit amounted to $55,026,169. As a result of the Company's history of losses and financial condition, there is substantial doubt about the ability of the Company to continue as a going concern.

The ability to continue as a going concern is dependent upon the Company generating profitable operations in the future and/or obtaining the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they come due. Management is evaluating different strategies to obtain financing to fund the Company's expenses and achieve a level of revenue adequate to support the Company's current cost structure. Financing strategies may include, but are not limited to, private placements of capital stock, debt borrowings, partnerships and/or collaborations. There can be no assurance that any of these future-funding efforts will be successful. The consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might result from the outcome of this uncertainty.

**Basis of presentation** – The company prepares its consolidated financial statements based upon the accrual method of accounting, recognizing income when earned and expenses when incurred.

**Consolidation** – The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, Blockchain Training Alliance and CoinTracking LLC which is inactive. All significant intercompany accounts and transactions are eliminated in consolidation.

**Use of estimates** – The preparation of these consolidated financial statements in conformity with US GAAP requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues, and expenses and the related disclosure of contingent assets and liabilities. The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. The Company's significant estimates and assumptions include but are not limited to the recoverability and useful lives of long-lived assets, allocation of revenue on software subscriptions, valuation of goodwill from business acquisitions, valuation and recoverability of investments, valuation allowances of deferred taxes, and share- based compensation expenses. Actual results may differ from these estimates. In addition, any change in these estimates or their related assumptions could have an adverse effect on the Company's operating results.

**Cash and cash equivalents** – The Company defines its cash and cash equivalents to include only cash on hand and certain highly liquid investments with original maturities of ninety days or less. The Company maintains its cash and cash equivalents at financial institutions, the balances of which may, at times, exceed federally insured limits. Management believes that the risk of loss due to the concentration is minimal.

**Investments in cryptocurrency** – Investments are comprised of several cryptocurrencies the Company owns, of which a majority is Bitcoin, that are actively traded on exchanges. The Company records its investments as indefinite-lived intangible assets at cost less impairment and are reported as long-term assets in the consolidated balance sheets. An intangible asset with an indefinite useful life is not amortized but assessed for impairment annually, or more frequently, when events or changes in circumstances occur indicating that it is more likely than not that the indefinite-lived asset is impaired. Impairment exists when the carrying amount exceeds its fair value. In testing for impairment, the Company has the option to first perform a qualitative assessment to determine whether it is more likely than not that an impairment exists. If it is determined that it is not more likely than not that an impairment exists, a quantitative impairment test is not necessary. If the Company concludes otherwise, it is required to perform a quantitative impairment test. To the extent an impairment loss is recognized, the loss establishes the new cost basis of the asset. Subsequent reversal of impairment losses is not permitted.

Realized gains and losses on sales of investments in cryptocurrency, and impairment losses, are included in other income/(expense) in the Consolidated Statements of Operations.

As of June 30, 2025 and 2024 there were $-0- in investments in cryptocurrency on the Company's Balance Sheet.

**Equipment** – Equipment is recorded at cost and depreciated using the straight-line method over the estimated useful life ranging from three to five years. Normal repairs and maintenance are expensed as incurred. Expenditures that materially adapt, improve, or alter the nature of the underlying assets are capitalized. When equipment is retired or otherwise disposed of, the cost and related accumulated depreciation are removed from the accounts, and the resulting gain or loss is credited or charged to income.

**Business combination –** The purchase price of an acquired company is allocated between tangible and intangible assets acquired and liabilities assumed from the acquired business based on their estimated fair values with the residual of the purchase price recorded as goodwill. The results of operations of acquired businesses are included in our operating results from the dates of acquisition.

**Goodwill and intangible assets** – The Company records the excess of purchase price over the fair value of the tangible and identifiable intangible assets acquired as goodwill. Intangible assets resulting from the acquisitions of entities accounted for using the purchase method of accounting are recorded at the estimated fair value of the assets acquired. Identifiable intangible assets are comprised of purchased customer relationships, trade names, and developed technologies. Intangible assets subject to amortization are amortized over the period of estimated economic benefit of five years. In accordance with ASC 350, Intangibles – Goodwill and Other ("ASC 350"), goodwill and other intangible assets with indefinite lives are not amortized but tested annually, on December 31, or more frequently if the Company believes indicators of impairment exist. Indefinite lived intangible assets also include investments in cryptocurrency (see Investments in Cryptocurrency).

The Company assesses whether goodwill impairment and indefinite lived intangible assets exists using both qualitative and quantitative assessments. The qualitative assessment involves determining whether events or circumstances exist that indicate it is more likely than not that the fair value of a reporting unit is less than its carrying amount, including goodwill. If based on this qualitative assessment the Company determines it is more likely than not that the fair value of a reporting unit is less than its carrying amount, or if the Company elects not to perform a qualitative assessment, a quantitative assessment is performed to determine whether a goodwill impairment exists at the reporting unit. As of December 31, 2023 the Company determined that its investment in BTA was fully impaired and recorded a loss of $1,271,306 in its Statement of Operations. As of June 30, 2025 and December 31, 2024 the Company had no goodwill or intangible assets.

**Income taxes –** Deferred tax assets and liabilities are recognized for expected future consequences of events that have been included in the consolidated financial statements or tax returns. Under the asset and liability method, deferred income tax assets and liabilities are determined based on the differences between the financial reporting and tax bases of assets and liabilities and are measured using the currently enacted tax rates and laws. A valuation allowance is provided for the amount of deferred tax assets that, based on available evidence, are not expected to be realized. The provision for income taxes represents the tax payable for the period and the change during the period in deferred tax assets and liabilities.

When tax returns are filed, it is highly certain that some positions taken would be sustained upon examination by the taxing authorities, while others are subject to uncertainty about the merits of the position taken or the amount of the position that would be ultimately sustained. The benefit of a tax position is recognized in the consolidated financial statements in the period during which, based on all available evidence, management believes it is more likely than not that the position will be sustained upon examination, including the resolution of appeals or litigation processes, if any. Tax positions taken are not offset or aggregated with other positions. Tax positions that meet the more-likely-than-not recognition threshold are measured as the largest amount of tax benefit that is more than 50 percent likely of being realized upon settlement with the applicable taxing authority. The portion of the benefits associated with tax positions taken that exceeds the amount measured as described above is reflected as a liability for unrecognized tax benefits along with any associated interest and penalties that would be payable to the taxing authorities upon examination.

As of June 30, 2025, we had a net operating loss carryforward for federal income tax purposes of approximately $55,000,000 portions of which will begin to expire in 2037. Utilization of some of the federal and state net operating loss and credit carryforwards are subject to annual limitations due to the "change in ownership" provisions of the Internal Revenue Code of 1986 and similar state provisions. The annual limitations may result in the expiration of net operating losses and credits before utilization.

**Fair value measurements** – The Company recognizes and discloses the fair value of its assets and liabilities using a hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to valuations based upon unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to valuations based upon unobservable inputs that are significant to the valuation (Level 3 measurements). Each level of input has different levels of subjectivity and difficulty involved in determining fair value.

---

| | |
|:---|:---|
| Level 1 | Inputs are unadjusted, quoted prices for identical assets or liabilities in active markets at the measurable date. |
| Level 2 | Inputs, other than quoted prices included in Level 1, which are observable for the asset or liability through corroboration with market data at the measurement date. |
| Level 3 | Unobservable inputs that reflect management's best estimate of what participants would use in pricing the asset or liability at the measurement date. |

---

The carrying amounts of the Company's financial assets and liabilities, including cash, accounts payable and accrued expenses approximate fair value because of the short maturity of these instruments.

**Revenue recognition** – The Company recognizes revenue under ASC 606, Revenue from Contracts with Customers ("ASC 606"). The core principle of the new revenue standard is that a company should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods or services. The following five steps are applied to achieve that core principle:

● Step 1: Identify the contract with the customer

● Step 2: Identify the performance obligations in the contract

● Step 3: Determine the transaction price

● Step 4: Allocate the transaction price to the performance obligations in the contract

● Step 5: Recognize revenue when the Company satisfies a performance obligation

In order to identify the performance obligations in a contract with a customer, a company must assess the promised goods or services in the contract and identify each promised good or service that is distinct. A performance obligation meets ASC 606's definition of a "distinct" good or service (or bundle of goods or services) if both of the following criteria are met: The customer can benefit from the good or service either on its own or together with other resources that are readily available to the customer (i.e., the good or service is capable of being distinct), and the entity's promise to transfer the good or service to the customer is separately identifiable from other promises in the contract (i.e., the promise to transfer the good or service is distinct within the context of the contract).

If a good or service is not distinct, the good or service is combined with other promised goods or services until a bundle of goods or services is identified that is distinct.

The transaction price is the amount of consideration to which an entity expects to be entitled in exchange for transferring promised goods or services to a customer. The consideration promised in a contract with a customer may include fixed amounts, variable amounts, or both. When determining the transaction price, an entity must consider the effects of all of the following:

Variable consideration is included in the transaction price only to the extent that it is probable that a significant reversal in the amount of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is subsequently resolved. The transaction price is allocated to each performance obligation on a relative standalone selling price basis. The transaction price allocated to each performance obligation is recognized when that performance obligation is satisfied, at a point in time or over time as appropriate.

The Company adopted ASC 606 as of January 1, 2018 using the modified retrospective transition method for contracts as of the date of initial application.

**Share-based compensation**

In accordance with ASC No. 718, Compensation – Stock Compensation ("ASC 718"), the Company measures the compensation costs of share-based compensation arrangements based on the grant date fair value of granted instruments and recognizes the costs in the consolidated financial statements over the period during which employees are required to provide services. Share-based compensation arrangements include stock options.

Equity instruments ("instruments") issued to non-employees are recorded on the basis of the fair value of the instruments, as required by ASC 718. ASC No. 505, Equity Based Payments to Non-Employees ("ASC 505"), defines the measurement date and recognition period for such instruments. In general, the measurement date is (a) when a performance commitment, as defined, is reached or (b) when the earlier of (i) the non-employee performance is complete and (ii) the instruments are vested. The compensation cost is remeasured at fair value at each reporting period when the award vests. As a result, stock option-based payments to non-employees can result in significant volatility in compensation expense.

The Company accounts for its share-based compensation using the Black-Scholes model to estimate the fair value of stock option awards. Using this model, fair value is calculated based on assumptions with respect to the (i) expected volatility of the Company's common stock price, (ii) expected life of the award, which for options is the period of time over which employees and non-employees are expected to hold their options prior to exercise, and (iii) risk-free interest rate.

**Net loss per common share** – The Company reports earnings per share ("EPS") with a dual presentation of basic EPS and diluted EPS. Basic EPS is computed as net income divided by the weighted average of common shares for the period. Diluted EPS reflects the potential dilution that could occur from common shares issued through stock options, or warrants. For the six months ended June 30, 2025 and the year ended December 31, 2024, the Company had no potentially dilutive common stock equivalents since the Company was in a loss position and inclusion of any equivalents would be anti-dilutive. Therefore, the basic EPS and the diluted EPS are the same.

**Reclassifications –** Certain amounts in the prior period consolidated financial statements have been reclassified to conform to the current period presentation. Such reclassifications had no effect on the Company's financial position, results of operations or cashflows.

**NOTE 3 – RECENT ACCOUNTING PRONOUNCEMENTS**

Management has considered all recent accounting pronouncements issued. The Company's management believes that these recent pronouncements will not have a material effect on the Company's financial statements.

**NOTE 4 – ACQUISITIONS AND AGREEMENTS**

On April 8, 2021, the Company completed the acquisition of all of the issued and outstanding stock of BTA and BTA became a wholly owned subsidiary of the Company. At the closing the Company delivered to the sellers a total of $600,000 in cash, promissory notes in the total principal amount of $150,000 bearing 1% interest per annum, and an aggregate of 201,439 shares of Company common stock valued at $604,317 in accordance with the terms of the SPA. Additionally, the Company acquired $4,860 in cash at BTA.

As a result of the foregoing the Company initially recorded goodwill of $1,349,457. The Company conducted a valuation study on the acquisition of BTA. The final valuation report determined the amount goodwill to be $740,469 and the remaining $650,000 of the goodwill relates to amortizable intangibles amortized over a fifteen-year period, or approximately $54,166 per year.

During the year ended December 31, 2023, the Company wrote off all of the goodwill and intangible assets of BTA amounting $1,271,306.

As a result of the operating results for BTA, the Company determined that its goodwill and intangible assets were fully impaired as of December 31, 2023, and recorded an impairment charge of $1,271,306 on it Statement of Operations.

As of June 30, 2025 we had no goodwill or intangible assets on our balance sheet.

**NOTE 5 – RELATED PARTY TRANSACTIONS**

Effective September 5, 2024, the Company amended its Articles of Incorporation (the "<u>Articles</u>"), to amend and restate Sections 1 and 2 of Article 4 of the Articles to increase the number of authorized shares of the Company's common stock ("<u>Common Stock</u>") from 2,000,000,000 to 19,000,000,000 and create a new class of stock, par value $0.001 per share, designated as Series A Preferred Stock consisting of 10 authorized shares, as set forth in Certificate of Amendment to the Articles of Incorporation (the "<u>Amendment</u>"). Pursuant to the Amendment, Common Stock and Preferred Stock are identical in all respects, except that each share of Common Stock is entitled to one vote and each share of Preferred Stock is entitled to 950,000,000 votes. The shares are not convertible to common stock

On the same date the Company entered into a stock agreement (the "<u>Stock Agreement</u>") with, the Company's CEO Ronald Levy pursuant to which the Company issued a total of ten (10) shares of the Company's Series A preferred stock ("<u>Preferred Stock</u>") Mr. Levy also serves Interim Chief Financial Officer, Chief Operating Officer, Chairman of the Board, Secretary, and a member of the Board of Directors of the Company.

Although the shares are not convertible to common stock these Series A Preferred Shares enable Mr. Levy to exercise control over the Company, so the company used the equity methos to value the shares. The 10 Series A Preferred shares convertible shares can be converted into 9,500,000,000 voting shares. As of December 31, 2024 the Company had 3,032,746,878 shares outstanding. The Company estimated that the voting shares could not exceed the number of shares outstanding and used that level of shares to value the common stock which was trading at $0.001 resulted in stock based compensation of $3,032,710 which was also equivalent to the market capitalization on that date.

On January 27, 2025 (the "Advance Date"), the Company entered into a Promissory Note with Ronald Levy, the Company's, Chief Executive Officer, Chief Operating Officer and Secretary, to obtain an advance in the amount of $15,000 (the "Loan") for the aforementioned Consultant engagement fee. The Loan bears interest at the rate of 5% per annum, with a maturity date four months from the Advance Date.

**NOTE 6 – NOTE PAYABLE**

As of June 30, 2025, Notes Payable amounted to $3,022,074. This balance is comprised of 17 individual notes due to AJB amounting to $3,013,290 (the "AJB Notes") and one note due to Fast Capital amounting to $8,784 (the "Fast Capital Note"). The accrued interest on the AJB Notes and Fast Capital Note amounted to $863,882 and $30,000, respectively. The summary of each Note outstanding is described as follows:

**<u>AJB NOTES</u>**

● On May 3, 2022, the Company borrowed funds pursuant to the terms of a Securities Purchase Agreement (the "May AJB SPA") entered into with AJB, and issued a Promissory Note in the principal amount of $1,180,000 (the "May AJB Note") to AJB in a private transaction for a purchase price of $900,000 (giving effect to a 10% original issue discount). In connection with the sale of the AJB Note, the Company also paid certain fees and due diligence costs of AJB and brokerage fees to J.H. Darbie & Co., a registered broker-dealer.

At the closing the Company repaid all obligations owed to AJB pursuant to a 10% promissory note in the principal amount of $750,000 issued in favor of AJB in January 2022 as generally described above. After the repayment of that promissory note, and after payment of the fees and costs, the $138,125 net proceeds from the issuance of the May AJB Note are expected to be utilized for working capital and other general corporate purposes.

The maturity date of the May ABJ Note is November 3, 2022, but it may be extended by the Company for six months with the interest rate to increase during the extension period. The May AJB Note bears interest at 10% per year, and principal and accrued interest is due on the maturity date. The Company may prepay the May AJB Note at any time without penalty. Under the terms of the May AJB Note, the Company may not sell a significant portion of its assets without the approval of AJB, may not issue additional debt that is not subordinate to AJB, must comply with the Company's reporting requirements under the Securities Exchange Act of 1934, and must maintain the listing of the Company's common stock on the OTC Market or other exchange, among other restrictions and requirements. The Company's failure to make required payments under the May AJB Note or to comply with any of these covenants, among other matters, would constitute an event of default. Upon an event of default under the May AJB SPA or May AJB Note, the May AJB Note will bear interest at 18%, AJB may immediately accelerate the May AJB Note due date, AJB may convert the amount outstanding under the May AJB Note into shares of Company common stock at a discount to the market price of the stock, and AJB will be entitled to its costs of collection, among other penalties and remedies.

Following an event of default, and subject to certain limitations, the outstanding amount of the Note may be converted into shares of Company common stock. Amounts due under the Note would be converted into shares of the Company's common stock at a conversion price equal to 75% of the lowest trading price with a 10-day lookback immediately preceding the date of conversion. In no event may the lender effect a conversion if such conversion, along with all other shares of Company common stock beneficially owned by the lender and its affiliates would exceed 4.99% of the outstanding shares of Company common stock. In addition, upon the occurrence and during the continuation of an event of default the Note will become immediately due and payable and the Company shall pay to the lender, in full satisfaction of its obligations thereunder, additional amounts as set forth in the Note.

As June 30, 2025 the principal balance on this AJB Note is $1,180,000.

● On June 23, 2023, the Company borrowed funds pursuant to the terms of a Securities Purchase Agreement (the "AJB SPA") entered into with AJB, and issued a Promissory Note in the principal amount of $550,000 (the "AJB June Note") to AJB in a private transaction for a purchase price of $500,000 (giving effect to a 10% original issue discount). In connection with the sale of the AJB June Note, the Company also paid certain fees and due diligence costs to AJB's management company and legal counsel. After payment of the fees and costs, the net proceeds to the Company were $487,500, which will be used for working capital and other general corporate purposes, provided that up to $200,000 may be drawn upon for potential acquisitions.

The maturity date of the AJB June Note is January 23, 2024. The AJB June Note bears interest at 12% per year, and principal and accrued interest is due on the maturity date. The Company may prepay the AJB June Note at any time without penalty. The AJB June Note contains standard and customary events of default, such as, among other restrictions and requirements, that the Company timely make payments under the AJB June Note; the Company may not sell a significant portion of its assets without the approval of AJB; the Company may not issue additional debt that is not subordinate to AJB; the Company must comply with the reporting requirements under the Securities Exchange Act of 1934; and the Company must maintain the listing of the Company's common stock on the OTC Market or other exchange. The Company's breach of any representation or warranty, or failure to comply with the covenants would constitute an event of default. Upon an event of default under the AJB SPA or AJB June Note, the AJB June Note will bear interest at 18%; AJB may immediately accelerate the AJB June Note due date; AJB may convert the amount outstanding under the AJB June Note into shares of Company common stock at a discount to the market price of the stock; and AJB will be entitled to its costs of collection, among other penalties and remedies.

As of June 30, 2025, the balancing remaining under this AJB Note is $550,000.

● On November 13, 2023, the Company borrowed funds pursuant to the terms of a Securities Purchase Agreement (the "Nov. SPA") entered into with AJB, and issued a Promissory Note in the principal amount of $500,000 to AJB (the "Nov. Note") in a private transaction for a purchase price of $425,000 (giving effect to an original issue discount). After payment of the fees and costs, the net proceeds to the Company were $405,000, which will be used for working capital and other general corporate purposes.

The maturity date of the Nov. Note is May 10, 2024. The Nov. Note bears interest at 12% per year, and principal and accrued interest is due on the maturity date. The Company may prepay the Nov. Note at any time without penalty. The Company's failure to make required payments under the Nov. Note or to comply with various covenants, among other matters, would constitute an event of default. Upon an event of default under the Nov. SPA or the Nov. Note, the Nov. Note will bear interest at 18%, AJB may immediately accelerate the Nov. Note due date, AJB may convert the amount outstanding under the Nov. Note into shares of Company common stock at a discount to the market price of the stock, and AJB will be entitled to its costs of collection, among other penalties and remedies.

As of June 30, 2025, the balancing remaining under this AJB Note is $95,243.

● On January 30, 2024, the Company borrowed funds pursuant to the terms of a Securities Purchase Agreement (the "January 30, 2024 SPA") entered into with AJB, and issued a Promissory Note in the principal amount of $50,000 to AJB (the "January 30, 2024 Note") in a private transaction for a purchase price of $42,500 (giving effect to an original issue discount). After payment of the fees and costs, the net proceeds to the Company were $40,000, which will be used for working capital and other general corporate purposes.

The maturity date of the January 30, 2024 Note is July 30, 2024. The January 30, 2024 Note bears interest at 12% per year, and principal and accrued interest is due on the maturity date. The Company may prepay the January 30, 2024 Note at any time without penalty. The Company's failure to make required payments under the January 30, 2024 Note or to comply with various covenants, among other matters, would constitute an event of default. Upon an event of default under the January 30, 2024 SPA or the January 30, 2024 Note will bear interest at 18%, AJB may immediately accelerate the January 30, 2024 Note due date, AJB may convert the amount outstanding under the January 30, 2024 Note into shares of Company common stock at a discount to the market price of the stock, and AJB will be entitled to its costs of collection, among other penalties and remedies.

As of June 30, 2025, the balancing remaining under this AJB Note is $50,000.

● On February 20, 2024, the Company borrowed funds pursuant to the terms of a Securities Purchase Agreement (the "February 20, 2024 SPA") entered into with AJB, and issued a Promissory Note in the principal amount of $53,000 to AJB (the "February 20, 2024 Note") in a private transaction for a purchase price of $45,050 (giving effect to an original issue discount). After payment of the fees and costs, the net proceeds to the Company were $40,050, which will be used for working capital and other general corporate purposes.

The maturity date of the February 20, 2024 Note is August 20, 2024. The February 20, 2024 Note bears interest at 12% per year, and principal and accrued interest is due on the maturity date. The Company may prepay the February 20, 2024 Note at any time without penalty. The Company's failure to make required payments under the February 20, 2024 Note or to comply with various covenants, among other matters, would constitute an event of default. Upon an event of default under the February 20, 2024 SPA or the February 20, 2024 Note, the February 20, 2024 Note will bear interest at 18%, AJB may immediately accelerate the February 20, 2024 Note due date, AJB may convert the amount outstanding under the February 20, 2024 Note into shares of Company common stock at a discount to the market price of the stock, and AJB will be entitled to its costs of collection, among other penalties and remedies.

As of June 30, 2025, the balancing remaining under this AJB Note is $53,000.

● On February 29, 2024, the Company borrowed funds pursuant to the terms of a Securities Purchase Agreement (the "February 29, 2024 SPA") entered into with AJB, and issued a Promissory Note in the principal amount of $159,000 to AJB (the "February 29, 2024 Note") in a private transaction for a purchase price of $135,000 (giving effect to an original issue discount). After payment of the fees and costs, the net proceeds to the Company were $130,000, which will be used for working capital and other general corporate purposes.

The maturity date of the February 29, 2024 Note is August 29, 2024. The February 29, 2024 Note bears interest at 12% per year, and principal and accrued interest is due on the maturity date. The Company may prepay the February 29, 2024 Note at any time without penalty. The Company's failure to make required payments under the February 29, 2024 Note or to comply with various covenants, among other matters, would constitute an event of default. Upon an event of default under the February 29, 2024 Note, the February 29, 2024 Note will bear interest at 18%, AJB may immediately accelerate the February 29, 2024 Note due date, AJB may convert the amount outstanding under the February 29, 2024 Note into shares of Company common stock at a discount to the market price of the stock, and AJB will be entitled to its costs of collection, among other penalties and remedies.

As of June 30, 2025, the balancing remaining under this AJB Note is $159,000.

● On April 12, 2024, the Company borrowed funds pursuant to the terms of a Securities Purchase Agreement (the "April 12, 2024 SPA") entered into with AJB, and issued a Promissory Note in the principal amount of $185,555 to AJB (the "April 12, 2024 Note") in a private transaction for a purchase price of $108,000 (giving effect to an original issue discount). After payment of the fees and costs, the net proceeds to the Company were $45,000, which will be used for working capital and other general corporate purposes.

The maturity date of the April 12, 2024 Note is October 12, 2024. The April 12, 2024 Note bears interest at 12% per year, and principal and accrued interest is due on the maturity date. The Company may prepay the April 12, 2024 Note at any time without penalty. The Company's failure to make required payments under the April 12, 2024 Note or to comply with various covenants, among other matters, would constitute an event of default. Upon an event of default under the April 12, 2024 SPA or the April 12, 2024 Note, the February 12, 2024 Note will bear interest at 18%, AJB may immediately accelerate the February 12, 2024 Note due date, AJB may convert the amount outstanding under the April 12, 2024 Note into shares of Company common stock at a discount to the market price of the stock, and AJB will be entitled to its costs of collection, among other penalties and remedies.

As of June 30, 2025, the balancing remaining under this AJB Note is $185,555.

● On May 31, 2024, the Company borrowed funds pursuant to the terms of a Securities Purchase Agreement (the "May 31, 2024 SPA") entered into with AJB, and issued a Promissory Note in the principal amount of $68,000 to AJB (the "May 31, 2024 Note") in a private transaction for a purchase price of $61,200 (giving effect to an original issue discount). After payment of the fees and costs, the net proceeds to the Company were $55,000, which will be used for working capital and other general corporate purposes.

The maturity date of the May 31, 2024 Note is December 1, 2024. The May 31, 2024 Note bears interest at 12% per year, and principal and accrued interest is due on the maturity date. The Company may prepay the May 31, 2024 Note at any time without penalty. The Company's failure to make required payments under the May 31, 2024 Note or to comply with various covenants, among other matters, would constitute an event of default. Upon an event of default under the May 31, 2024 SPA or the May 31, 2024 Note, the May 31, 2024 Note will bear interest at 18%, AJB may immediately accelerate the May 31, 2024 Note due date, AJB may convert the amount outstanding under the May 31, 2024 Note into shares of Company common stock at a discount to the market price of the stock, and AJB will be entitled to its costs of collection, among other penalties and remedies.

As of June 30, 2025, the balancing remaining under this AJB Note is $68,000.

● On June 18, 2024, the Company borrowed funds pursuant to the terms of a Securities Purchase Agreement (the "June 18, 2024 SPA") entered into with AJB, and issued a Promissory Note in the principal amount of $72,500 to AJB (the "June 18, 2024 Note") in a private transaction for a purchase price of $58,000 (giving effect to an original issue discount). After payment of the fees and costs, the net proceeds to the Company were $18,000, which will be used for working capital and other general corporate purposes.

The maturity date of the June 18, 2024 Note is December 18, 2024. The June 18, 2024 Note bears interest at 12% per year, and principal and accrued interest is due on the maturity date. The Company may prepay the June 18, 2024 Note at any time without penalty. The Company's failure to make required payments under the June 18, 2024 Note or to comply with various covenants, among other matters, would constitute an event of default. Upon an event of default under the June 18, 2024 SPA or the June 18, 2024 Note, the June 18, 2024 Note will bear interest at 18%, AJB may immediately accelerate the June 18, 2024 Note due date, AJB may convert the amount outstanding under the June 18, 2024 Note into shares of Company common stock at a discount to the market price of the stock, and AJB will be entitled to its costs of collection, among other penalties and remedies.

As of June 30, 2025, the balancing remaining under the AJB June Note is $72,500.

● On July 15, 2024, the Company borrowed funds pursuant to the terms of a Securities Purchase Agreement (the "July 15, 2024 SPA") entered into with AJB, and issued a Promissory Note in the principal amount of $59,000 to AJB (the "July 15, 2024 Note") in a private transaction for a purchase price of $47,200 (giving effect to an original issue discount). After payment of the fees and costs, the net proceeds to the Company were $44,700, which will be used for working capital and other general corporate purposes.

The maturity date of the July 15, 2024 Note is January 15, 2025. The July 15, 2024 Note bears interest at 12% per year, and principal and accrued interest is due on the maturity date. The Company may prepay the July 15, 2024 Note at any time without penalty. The Company's failure to make required payments under the July 15, 2024 Note or to comply with various covenants, among other matters, would constitute an event of default. Upon an event of default under the July 15, 2024 SPA or the July 15, 2024 Note, the July 15, 2024 Note will bear interest at 18%, AJB may immediately accelerate the July 15, 2024 Note due date, AJB may convert the amount outstanding under the July 15, 2024 Note into shares of Company common stock at a discount to the market price of the stock, and AJB will be entitled to its costs of collection, among other penalties and remedies.

As of June 30, 2025, the balancing remaining under this AJB Note is $59,000.

● On August 28, 2024, the Company borrowed funds pursuant to the terms of a Securities Purchase Agreement (the "August 28, 2024 SPA") entered into with AJB, and issued a Promissory Note in the principal amount of $157,556 to AJB (the "August 28, 2024 Note") in a private transaction for a purchase price of $108,000 (giving effect to an original issue discount). After payment of the fees and costs, the net proceeds to the Company were $98,000, which will be used for working capital and other general corporate purposes.

On January 27, 2025, the Company and AJB Capital Investments LLC entered into a Second Amendment dated as of October 10, 2024 ("Second Amendment"), to that certain Promissory Note dated as of August 28, 2024 ("Promissory Note"). The First Amendment to the Promissory Note dated as of October 1, 2024 ("First Amendment"), amends the Promissory Note, to increase the principal amount of the Promissory Note from $120,000 to $142,000. The Second Amendment to the Promissory Note amends the Promissory Note, as amended by the First Amendment, to increase the principal amount of the Promissory Note from $142,000 to $157,556, provided, however, that the $15,556 of additional principal carries an original issue discount of $1,556 withheld from the Company to cover monitoring costs associated with the Promissory Note.

On February 11, 2025, the Company and AJB Capital Investments LLC entered into a Third Amendment dated as of February 6, 2025 ("Third Amendment") to that certain Promissory Note dated as of August 28, 2024 ("Promissory Note"). The First Amendment to the Promissory Note dated as of October 1, 2024 ("First Amendment"), amends the Promissory Note, to increase the principal amount of the Promissory Note from $120,000 to $142,000. The Second Amendment to the Promissory Note amends the Promissory Note, as amended by the First Amendment, to increase the principal amount of the Promissory Note from $142,000 to $157,556. The Third Amendment to the Promissory Note amends the Promissory Note, as amended by the First and Second Amendments, to increase the principal amount of the Promissory Note from $157,556 to $222,890, provided, however, that the $65,334 of additional principal carries an original issue discount of $6,534 withheld from the Company to cover monitoring costs associated with the Promissory Note and $3,500 withheld from the Company to cover due diligence and legal costs in connection with the Third Amendment.

The Company and AJB Capital Investments LLC entered into a Fourth Amendment dated as of March 10, 2025 ("Fourth Amendment") to that certain Promissory Note dated as of August 28, 2024 ("Promissory Note"). The First Amendment to the Promissory Note dated as of October 1, 2024 ("First Amendment"), amends the Promissory Note, to increase the principal amount of the Promissory Note from $120,000 to $142,000. The Second Amendment to the Promissory Note amends the Promissory Note, as amended by the First Amendment, to increase the principal amount of the Promissory Note from $142,000 to $157,556. The Third Amendment to the Promissory Note amends the Promissory Note, as amended by the First and Second Amendments, to increase the principal amount of the Promissory Note from $157,556 to $222,890. The Fourth Amendment to the Promissory Note amends the Promissory Note, as amended by the First, Second, and Third Amendments, to increase the principal amount of the Promissory Note from $22,890 to $252,890, provided, however, that the $30,000 of additional principal carries an original issue discount of $3,000 withheld from the Company to cover monitoring costs associated with the Promissory Note and $2,000 withheld from the Company to cover due diligence and legal costs in connection with the Fourth Amendment.

The Fifth Amendment to the Promissory Note entered into on May 13, 2025, amends the Promissory Note, as amended by the First, Second, Third, and Fourth Amendments, to increase the principal amount of the Promissory Note from $252,890 to $325,113, provided, however, that the $72,223 of additional principal carries an original issue discount of $7,223 withheld from the Company to cover monitoring costs associated with the Promissory Note and $4,000 withheld from the Company to cover due diligence and legal costs in connection with the Fifth Amendment. In exchange for the additional principal, the Company issued AJB Capital Investments LLC a pre-funded warrant to purchase up to 25,000,000 shares of Common Stock of the Company for a nominal exercise price of $0.00001 per warrant share ("Pre-Funded Warrant"). The Warrant includes various covenants of the Company for the benefit of the Warrant holder such as a beneficial ownership limitation on the holder that, in certain circumstances, may serve to restrict the holder's right to exercise the Warrant.

The maturity date of the August 28, 2024 Note was February 28, 2025. The August 28, 2024 Note bears interest at 12% per year, and principal and accrued interest is due on the maturity date. The Company may prepay the August 28, 2024 Note at any time without penalty. The Company's failure to make required payments under the August 28, 2024 Note or to comply with various covenants, among other matters, would constitute an event of default. Upon an event of default under the August 28, 2024 SPA or the August 28, 2024 Note, the August 28, 2024 Note will bear interest at 18%, AJB may immediately accelerate the August 28, 2024 Note due date, AJB may convert the amount outstanding under the August 28, 2024 Note into shares of Company common stock at a discount to the market price of the stock, and AJB will be entitled to its costs of collection, among other penalties and remedies.

As of June 30, 2025, the balancing remaining under this AJB Note is $325,113.

● On November 1, 2024, the Company borrowed funds pursuant to the terms of a Securities Purchase Agreement (the "November 1, 2024 SPA") entered into with AJB, and issued a Promissory Note in the principal amount of $48,600 to AJB (the "November 1, 2024 Note") in a private transaction for a purchase price of $29,700 (giving effect to an original issue discount). After payment of the fees and costs, the net proceeds to the Company were $24,700, which will be used for working capital and other general corporate purposes.

On January 10, 2025, the Company and AJB Capital Investments LLC entered into a Second Amendment dated as of January 8, 2025 ("Second Amendment"), to that certain Promissory Note dated as of November 1, 2024 ("Promissory Note"). The First Amendment to the Promissory Note dated as of November 18, 2024 ("First Amendment"), amended the Promissory Note to increase the principal amount of the Promissory Note from $33,000 to $48,600. The Second Amendment to the Promissory Note amends the Promissory Note, as amended by the First Amendment, to increase the principal amount of the Promissory Note from $48,600 to $81,934, provided, however, that the $33,334 of additional principal carries an original issue discount of $3,334 withheld from the Company to cover monitoring costs associated with the Promissory Note.

The maturity date of the November 1, 2024 Note is May 1, 2025. The November 1, 2024 Note bears interest at 12% per year, and principal and accrued interest is due on the maturity date. The Company may prepay the November 1, 2024. Note at any time without penalty. The Company's failure to make required payments under the November 1, 2024 Note or to comply with various covenants, among other matters, would constitute an event of default. Upon an event of default under the November 1, 2024 SPA or the November 1, 2024 Note, the November 1, 2024 Note will bear interest at 18%, AJB may immediately accelerate the November 1, 2024 Note due date, AJB may convert the amount outstanding under the November 1, 2024 Note into shares of Company common stock at a discount to the market price of the stock, and AJB will be entitled to its costs of collection, among other penalties and remedies.

As of June 30, 2025, the balancing remaining under this AJB Note is $81,934.

● On December 4, 2024, the Company borrowed funds pursuant to the terms of a Securities Purchase Agreement (the "December 4, 2024 SPA") entered into with AJB, and issued a Promissory Note in the principal amount of $36,500 to AJB (the "December 4, 2024 Note") in a private transaction for a purchase price of $32,850 (giving effect to an original issue discount). After payment of the fees and costs, the net proceeds to the Company were $27,850, which will be used for working capital and other general corporate purposes. The maturity date of the December 4, 2024 Note is June 4, 2025.

The December 4, 2024 Note bears interest at 12% per year, and principal and accrued interest is due on the maturity date. The Company may prepay the December 4, 2024 Note at any time without penalty. The Company's failure to make required payments under the December 4, 2024 Note or to comply with various covenants, among other matters, would constitute an event of default. Upon an event of default under the December 4, 2024 SPA or the December 4, 2024 Note, the December 4, 2024 Note will bear interest at 18%, AJB may immediately accelerate the December 4, 2024 Note due date, AJB may convert the amount outstanding under the December 4, 2024 Note into shares of Company common stock at a discount to the market price of the stock, and AJB will be entitled to its costs of collection, among other penalties and remedies.

As of June 30, 2025, the balancing remaining under this AJB Note is $36,500.

● On February 20, 2025, the Company borrowed funds pursuant to the terms of a Securities Purchase Agreement (the "February 20, 2024 SPA") entered into with AJB, and issued a Promissory Note in the principal amount of $29,445 to AJB (the "February 20, 2025 Note") in a private transaction for a purchase price of $26,500 (giving effect to an original issue discount). After payment of the fees and costs, the net proceeds to the Company were $20,000, which will be used for working capital and other general corporate purposes. The maturity date of the February, 2025 Note is August 20, 2025.

The February 20, 2025 Note bears interest at 12% per year, and principal and accrued interest is due on the maturity date. The Company may prepay the February 20, 2025 Note at any time without penalty. The Company's failure to make required payments under the February 20, 2025 Note or to comply with various covenants, among other matters, would constitute an event of default. Upon an event of default under the February 20, 2025 SPA or the February 20, 2025 Note, the February 20, 2025 Note will bear interest at 18%, AJB may immediately accelerate the February 20, 2025 Note due date, AJB may convert the amount outstanding under the February 20, 2025 Note into shares of Company common stock at a discount to the market price of the stock, and AJB will be entitled to its costs of collection, among other penalties and remedies.

As of June 30, 2025, the balancing remaining under this AJB Note is $29,445.

● The Company borrowed funds pursuant to the terms of a Securities Purchase Agreement (the "AJB SPA") entered into with AJB Capital Investments, LLC ("AJB"), and issued both a Promissory Note in the principal amount of $68,000 (the "AJB Note") to AJB in a private transaction for a purchase price of $61,200 and a Pre-Funded Common Stock Purchase Warrant (the "AJB Warrant"), which entitles AJB to subscribe for and purchase from the Company up to 50,000,000 shares of the Company's common stock, each executed on June 30, 2025. In connection with the sale of the AJB Note, the Company also paid certain fees and expenses of AJB. After payment of the fees and expenses, the net proceeds to the Company is $51,381.35, which will be available at such times as an advance is requested by the Company pursuant to a Borrowing Notice (as defined in the Note).

The maturity date of the AJB Note is December 11, 2025. The AJB Note bears interest at a rate of twelve percent (12%) per calendar year from the date of issuance. The interest shall accrue on a monthly basis and is payable on the maturity date or upon acceleration or by prepayment or otherwise. The Company may prepay the AJB Note at any time without penalty. Under the terms of the AJB Note, the Company may not issue additional debt that is not subordinate to AJB, must comply with the Company's reporting requirements under the Securities Exchange Act of 1934, and must maintain the listing of the Company's common stock on the OTC Market or other exchange, among other restrictions and requirements. The Company's failure to make required payments under the AJB Note or to comply with any of these covenants, among other matters, would constitute an event of default. Upon an event of default under the AJB SPA or AJB Note, the AJB Note will bear interest at the lesser of 18% per annum or the maximum amount permitted under law, AJB may immediately accelerate the AJB Note due date, AJB may convert the amount outstanding under the AJB Note into shares of Company common stock at a discount to the market price of the stock, and AJB will be entitled to its costs of collection, among other penalties and remedies.

The AJB Warrant entitles AJB to subscribe for and purchase from the Company up to 50,000,000 shares of the Company's common stock. The aggregate exercise price of the AJB Warrant was pre-funded to the Company. Consequently, AJB need not pay any additional consideration to exercise the AJB Warrant, other than a nominal exercise price of $.00001 per share. If the Company, while the AJB Warrant is outstanding, engages in a fundamental transaction, including, but not limited to, a merger, a disposition of all or substantially all of its assets, or a consummation of a stock purchase agreement that results in a change of control, then AJB shall have the right to receive, for each share of common stock that would have been issuable prior to the occurrence of such a fundamental transaction, the number of shares of capital stock of the successor, of the acquiring corporation, or of the Company if it is the surviving corporation, and any additional consideration receivable as a result of such a fundamental transaction by a holder of the number of shares of common stock for which the AJB Warrant is immediately exercisable prior to such a fundamental transaction.

The Company provided various representations, warranties, and covenants to AJB in the AJB SPA. The Company's breach of any representation or warranty, or failure to comply with the covenants would constitute an event of default.

The Company also entered into a Security Agreement with AJB pursuant to which the Company granted to AJB a security interest in all of the Company's assets to secure the Company's obligations under the AJB SPA and AJB Note.

The foregoing descriptions of the AJB SPA, AJB Note, AJB Warrant, and Security Agreement do not purport to be complete and are qualified in their entirety by the full text of the forms of the AJB SPA, AJB Note, AJB Warrant, and Security Agreement which will be filed as exhibits to a subsequent quarterly report to be filed by the Company.

As of June 30, 2025, the balancing remaining under this AJB Note is $68,000.

**<u>FAST CAPITAL</u>**

On February 2, 2023, the Company borrowed funds pursuant to a SPA entered into with Fast Capital, LLC ("Fast Capital"), and Fast Capital purchased a 10% convertible promissory note (the "Fast Capital Note") from the Company in the aggregate principal amount of $115,000. The Fast Capital Note has an original issue discount of $10,000, resulting in gross proceeds to the Company of $105,000. Pursuant to the SPA, the Company agreed to reimburse Fast Capital for certain fees in connection with entry into the SPA and the issuance of the Fast Capital Note. The SPA contains certain covenants and customary representations and warranties by the Company and Fast Capital typically contained in such documents.

The maturity date of the Fast Capital Note is January 30, 2024. The Fast Capital Note bears interest at a rate of 10% per annum, and a default interest of 24% per annum. Interest is payable in shares of Company common stock.

For the first six months, the Company has the right to prepay principal and accrued interest due under the Fast Capital Note at a premium of between 15% and 40% depending on when it is repaid. The Fast Capital Note may not be prepaid after the 180th day of its issuance.

Fast Capital has the right at any time after the six-month anniversary of the date of issuance of the Fast Capital Note to convert all or any part of the outstanding and unpaid principal amount of the Fast Capital Note into Company common stock, subject to a beneficial ownership limitation. The conversion price of the Fast Capital Note equals 60% of the lowest closing price of the Company's common stock for the 20 prior trading days, including the day upon which a notice of conversion is delivered.

The Fast Capital Note contains various covenants standard and customary events of default such as failing to timely make payments under the Fast Capital Note when due, the failure to maintain a listing on the OTC Markets or the Company defaulting on any other note or similar debt obligation into which the Company has entered and failed to cure within the applicable grace period. The occurrence of any of the events of default, entitle First Capital, among other things, to accelerate the due date of the unpaid principal amount of, and all accrued and unpaid interest on, the Fast Capital Note. Upon an "Event of Default", interest shall accrue at a default interest rate of 24%, and certain defined events of default may give rise to other remedies (such as, if the Company is delinquent in its periodic report filings with the Securities and Exchange Commission then the conversion price of the Fast Capital Note may be decreased).

As of June 30, 2025, the balancing remaining under the Fast Capital Note is $8,784, with accrued interest of $30,000.

**<u>Notes Payable -Other</u>**

**SBA Loans**

● On June 10, 2020, the Company received a loan from the Small Business Administration of $12,100 (the "2020 SBA Loan"). The 2020 SBA Loan bears interest at 3.75% per annum and is payable over 30 years with all payments of principal and interest deferred for the first 12 months.

● On February 2, 2021, the Company received a loan from the Small Business Administration of $18,265 (the "2021 SBA Loan"). The 2021 SBA Loan bears interest at 1% per annum and is payable over 5 years with all payments of principal and interest deferred for the first 10 months.

As of June 30, 2025 the total due on the SBA loans amounted to $12,330.

**NOTE 7 – OTHER LIABILITIES**

During the year ended December 31, 2023 the Company initially recorded $207,938 in revenue that it could not document as revenue under the guidelines of ASC 606. As a result the Company reclassified this amount of cash received as "Other Liabilities".

**NOTE 8 – EQUITY**

*<u>Common stock</u>*

As of June 30, 2025, the Company had 19,000,000,000 shares of $0.001 common stock authorized. As of June 30, 2025 there were 3,900,220,360 and 3,032,746,878 and shares of common stock outstanding, respectively.

On January 23, 2025 (the "Effective Date"), the Company entered into a consulting agreement (the "Consulting Agreement") with YWRC Holdings, Inc. (the "Consultant"). The Consulting Agreement has an initial term of six months, commencing on the Effective Date. The Consultant received a one-time engagement fee on the Effective Date and is eligible to receive a monthly fee for its services during the term of the Consulting Agreement in accordance with the terms and conditions of the Consulting Agreement, totaling up to a cumulative $1,015. In addition, the Consultant will receive an award of 4.99% of the Company's common stock, par value $0.001 per share (the "Common Stock"), subject to the Consultant's continued compliance with the terms of the Consulting Agreement; provided, Consultant will be eligible to receive an additional equity award at the 12-month anniversary of the Effective Date to ensure that Consultant hold as total equity interest equal to 4.99% of the fully diluted outstanding shares of the Company. Consultant shall not sell, transfer, or otherwise dispose of more than 5% of the total trading volume of the Company Common Stock, as traded on the applicable stock exchange or market, during any calendar month, calculated based on the total trading volume during the previous calendar month. The Company may terminate the Consulting Agreement at any time with at least 30 days' prior written notice. The Consultant will be an independent contractor of the Company, and as such, the Consultant is not entitled to participate in any Company employee benefit plans.

On May 23, 2025, the Company issued a total of 83,603,144 shares of common stock, in lieu of cash to seven different consultants proving services to the Company.

On June 24, 2025 and June 25, 2025, the Company entered into stock agreement with five recipients to issue a total of 386,459,998 shares as a bonus to employees and contractors for services. Ronald Levy the Company's CEO received 197,605,773 of those Common Shares and Holly Ruxin, a director, received 67,106,721 of those Common Shares. The Common Shares received by Mr. Levy and Ms. Ruxin were on the same terms and conditions as the other Recipients.

*<u>Preferred A Stock</u>*

Effective September 5, 2024, the Company amended its Articles of Incorporation (the "<u>Articles</u>"), to amend and restate Sections 1 and 2 of Article 4 of the Articles to increase the number of authorized shares of the Company's common stock ("<u>Common Stock</u>") from 2,000,000,000 to 19,000,000,000 and create a new class of stock, par value $0.001 per share, designated as Series A Preferred Stock consisting of 10 authorized shares, as set forth in Certificate of Amendment to the Articles of Incorporation (the "<u>Amendment</u>"). Pursuant to the Amendment, Common Stock and Preferred Stock are identical in all respects, except that each share of Common Stock is entitled to one vote and each share of Preferred Stock is entitled to 950,000,000 votes. The shares are not convertible to common stock

On the same date the Company entered into a stock agreement (the "<u>Stock Agreement</u>") with, the Company's CEO Ronald Levy pursuant to which the Company issued a total of ten (10) shares of the Company's Series A preferred stock ("<u>Preferred Stock</u>") Mr. Levy also serves Interim Chief Financial Officer, Chief Operating Officer, Chairman of the Board, Secretary, and a member of the Board of Directors of the Company.

Although the shares are not convertible to common stock these Series A Preferred Shares enable Mr. Levy to exercise control over the Company, so the company used the equity methos to value the shares. The 10 Series A Preferred shares convertible shares can be converted into 9,500,000,000 voting shares. as of December 31, 2024 the Company had 3,032,746,878 shares outstanding. The company estimated that the voting shares could not exceed the number of shares outstanding and used that level of shares to value the common stock which was trading at $0.001 resulted in stock based compensation of $3,032,710 which was also equivalent to the market capitalization on that date.

*<u>Stock Options</u>*

On July 21, 2017, the Company's board of directors adopted The Crypto Company 2017 Equity Incentive Plan (the "Plan"), which was approved by its stockholders on August 24, 2017. The Plan is administered by the board of directors (the "Administrator"). Under the Plan, the Company may grant equity awards to eligible participants which may take the form of stock options (both incentive stock options and non-qualified stock options) and restricted stock awards. Awards may be granted to officers, employees, non-employee directors (as defined in the Plan) and other key persons (including consultants and prospective employees). The term of any stock option award may not exceed 10 years and may be subject to vesting conditions, as determined by the Administrator. Options granted generally vest over eighteen to thirty-six months. Incentive stock options may be granted only to employees of the Company or any subsidiary that is a "subsidiary corporation" within the meaning of Section 424(f) of the Internal Revenue Code.

During the year ended December 31, 2020, the Company issued 500,000 stock options to members of its board of directors, 1,250,000 stock options to employees, and 170,000 stock options to non-employees. No stock options were issued in 2024.

5,000,000 shares of the Company's common stock are reserved for issuance under the Plan. As of June 30, 2025, there are outstanding stock option awards issued from the Plan covering a total of 2,281,349 shares of the Company's common stock and there remain reserved for future awards 2,718,651 shares of the Company's common stock.

---

| | | | |
|:---|:---|:---|:---|
|  | **Number<br> of Shares** | **Weighted<br> Average<br> Exercise<br> Price** | **Weighted<br> Average<br> Remaining<br> Contractual<br> Term<br> (years)** |
| Options outstanding, at December 31, 2023 | 2281349 | $2.26 | 2.25 |
| Options granted |  |  |  |
| Options cancelled |  |  |  |
| Options exercised |  |  |  |
| Options outstanding, at December 31, 2024 | 2281349 | $2.26 | 1.25 |
| Options granted |  |  |  |
| Options cancelled |  |  |  |
| Options exercised | - |  |  |
| Options vested and outstanding, at June 30, 2025 | 2281349 | $2.26 | 1.00 |

---

The Company recognized $-0- and $-0- of compensation expense related to stock options for the six months ended June 30, 2025 and 2024, respectively. As of June 30, 2025 these options had no intrinsic value since they were all out of the money as of June 30, 2025.

The determination of the fair value of share-based compensation awards utilizing the Black-Scholes model is affected by the Company's stock price and a number of complex and subjective assumptions, including stock price, volatility, expected life of the equity award, forfeitures rates if any, risk-free interest rates and expected dividends. Volatility is based on the historical volatility of comparable companies measured over the most recent period, generally commensurate with the expected life of the Company's stock options, adjusted for future expectations given the Company's limited historical share price data.

As of June 30, 2025 the following warrants were outstanding:

---

| | | | | |
|:---|:---|:---|:---|:---|
| Issuance Date | Exercisable for | Expiration Date | Exercise Price | **Number of**<br> **Shares**<br> **Outstanding**<br> **Under Warrants** |
| February 2020 | Common Shares | February 6, 2030 | $0.01 | 10000 |
| February 2020 | Common Shares | February 12, 2030 | $0.01 | 2500 |
| February 2020 | Common Shares | February 19, 2030 | $0.01 | 10000 |
| April 2020 | Common Shares | April 20, 2030 | $0.01 | 22500 |
| June 2020 | Common Shares | June 9, 2030 | $0.01 | 5000 |
| March 2021 | Common Shares | February 28, 2026 | $0.50 | 362500 |
| January 2022 | Common Shares | January 12, 2025 | $5.25 | 500000 |
| February 2022 | Common Shares | February 24, 2025 | $5.25 | 200000 |
| April 2022 | Common Shares | April 7, 2025 | $5.25 | 146667 |
| May 2022 | Common Stock | May 3, 2025 | $5.25 | 750000 |
| March 2023 | Common Stock | March 8, 2028 | $0.00001 | 474780 |
| March 2023 | Common Stock | March 13, 2028 | $0.00001 | 7000000 |
| April 2023 | Common Stock | April 14. 2028 | $0.00001 | 1000000 |
| May 2023 | Common Stock | May 12, 2028 | $0.00001 | 30000000 |
| June 2023 | Common Stock | June 23, 2028 | $0.00001 | 1500000 |
| November 2023 | Common Stock | November 13, 2028 | $0.00001 | 10000000 |
| April 2024 | Common Stock | April 12, 2029 | $0.00001 | 5000000 |
| May 2024 | Common Stock | May 31, 2029 | $0.00001 | 5000000 |
| February 2025 | Common Stock | February 2030 | $0.00001 | 15000000 |
| May 2025 | Common Stock | May 6, 2030 | $0.00001 | 25000000 |
| February 2025 | Common Stock | June 30, 2030 | $0.00001 | 50000000 |

---

**NOTE 9 - COMMITMENTS AND CONTINGENCIES**

*Legal Contingencies*

The Company may from time to time become subject to legal proceedings, claims, and litigation arising in the ordinary course of business.

Indemnities and guarantees - During the normal course of business, the Company has made certain indemnities and guarantees under which it may be required to make payments in relation to certain transactions. These indemnities include certain agreements with the Company's officers and directors, under which the Company may be required to indemnify such persons for liabilities arising out of their respective relationships. In connection with its facility lease, the Company has indemnified the lessor for certain claims arising from the use of the facility. The duration of these indemnities and guarantees varies and, in certain cases, is indefinite. The majority of these indemnities and guarantees do not provide for any limitation of the maximum potential future payments the Company could be obligated to make. Historically, the Company has not been obligated to make significant payments for these obligations, and no liabilities have been recorded for these indemnities and guarantees in the accompanying balance sheet.

**NOTE 10 - SUBSEQUENT EVENTS**

The Company borrowed funds from Three Mile Creek Future LLC ("TMCF") and issued a Promissory Note (the "Note") in the principal amount of 1.7 Bitcoin and a Pre-Funded Common Stock Purchase Warrant (the "Warrant"), which entitles TMCF to subscribe for and purchase from the Company up to 77,704,407 shares of the Company's common stock, each executed on July 16, 2025.

The principal balance of the Note will be payable on January 10, 2026. The Note bears no interest and can be pre-paid by the Company any time without penalty. To secure the payment and performance of all obligations under the Note, the Company granted to TMCF a continuing security interest in all assets of the Company (the "Collateral"). Upon event of default, the unpaid principal balance of the Note will immediately become due and payable, and TMCF will have all rights and remedies available to it under the Nevada Uniform Commercial Code, including the right to take possession of the Collateral and to sell or otherwise dispose of it. AJB Capital Investments LLC, which holds a first priority security interest in the Collateral, has consented to the creation of the TMCF security interest in the Collateral and agreed to subordinate its lien to TMCF's security interest.

The Warrant entitles TMCF to subscribe for and purchase from the Company up to 77,704,407 shares of the Company's common stock any time prior to July 10, 2030. The aggregate exercise price of the TMCF Warrant was pre-funded to the Company. Consequently, TMCF need not pay any additional consideration to exercise the Warrant, other than a nominal exercise price of $0.03 per share.

The Warrant is exercisable at any time on or after the date of issuance and expires five years after the date of issuance.

***Consulting Agreement***

On July 22, 2025, the Company entered into a Consulting Agreement effective as of July 1, 2025, with Rafael Furst (the "Consultant") in connection with Consultant's appointment as the Company's Chief Strategy Officer (the "Consulting Agreement").

Under the terms of the Consulting Agreement, the Consultant will serve as an independent contractor and provide strategic advisory services to the Company, including advising on the implementation of the Company's crypto treasury strategy, blockchain education platform, M&A initiatives, and cross-platform product development over a three-month term, unless earlier terminated or extended by mutual written agreement of the parties. In consideration for the services, the Consultant will receive a total of $75,000 for the three-month term, payable on October 1, 2025, in cash or, at the Company's sole discretion, in fully vested shares of the Company's common stock at a 25% discount to the volume-weighted average price over the 10 trading days immediately preceding the payment date. The shares issued will be subject to restrictions under the Securities Act of 1933, as amended.

Either party may terminate the Consulting Agreement at any time prior to the expiration of the term by mutual written agreement. The Consulting Agreement will automatically terminate upon the execution of a definitive employment agreement between the Company and the Consultant.

**ITEM 2. Management's Discussion and Analysis of Financial Condition and Results of Operations.**

*You should read the following discussion of our financial condition and results of operations in conjunction with the consolidated financial statements and the related notes included elsewhere in this Quarterly Report on Form 10-Q ("Quarterly Report") and with our audited consolidated financial statements, including the notes thereto, and Management's Discussion and Analysis of Financial Condition and Results of Operations included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2024 (the "2024 Annual Report"), as filed with the U.S. Securities and Exchange Commission ("SEC"). In addition to historical consolidated financial information, the following discussion and analysis contain forward-looking statements that reflect our plans, estimates, and beliefs and involve risks and uncertainties. The words "may," "could," "should," "estimate," "project," "forecast," "intend," "expect," "anticipate," "believe," "target," "plan" and similar expressions are intended to identify forward-looking statements. Our actual results could differ materially from those anticipated in the forward-looking statements. Factors that could cause or contribute to these differences include those discussed below and elsewhere in this Quarterly Report, as well as risks referenced in our other filings with the SEC.*

**Overview of Our Business**

We are primarily engaged in the business of providing consulting, training, and educational services for distributed ledger technologies ("blockchain"), for individual and corporate clients, enterprises for general blockchain education, as well as for the building of technological infrastructure and enterprise blockchain technology solutions. We currently generate revenues and incur expenses through these consulting and educational operations. We have disposed of our entire ownership interest in CoinTracking GmbH and also divested all of our cryptocurrency assets owned by our former cryptocurrency investment segment, which has ceased operations.

The Company entered into a Stock Purchase Agreement (the "SPA") effective as of March 24, 2021 with Blockchain Training Alliance, Inc ("BTA") and its stockholders. On April 8, 2021, the Company completed the acquisition of all of the issued and outstanding stock of BTA and BTA became a wholly owned subsidiary of the Company.

BTA is a blockchain training company and service provider that provides training and educational courses focused on blockchain technology and education as to the general understanding of blockchain to corporate and individual clients.

***Recent Developments***

Effective September 5, 2024, the Company amended its Articles of Incorporation (the "<u>Articles</u>"), to amend and restate Sections 1 and 2 of Article 4 of the Articles to increase the number of authorized shares of the Company's common stock ("<u>Common Stock</u>") from 2,000,000,000 to 19,000,000,000 and create a new class of stock, par value $0.001 per share, designated as Series A Preferred Stock consisting of 10 authorized shares, as set forth in Certificate of Amendment to the Articles of Incorporation (the "<u>Amendment</u>"). Pursuant to the Amendment, Common Stock and Preferred Stock are identical in all respects, except that each share of Common Stock is entitled to one vote and each share of Preferred Stock is entitled to 950,000,000 votes.

Effective September 5, 2024, the Company entered into a stock agreement (the "<u>Stock Agreement</u>") with Ronald Levy (the "<u>Recipient</u>"), pursuant to which the Company issued a total of ten (10) shares of the Company's Series A preferred stock ("<u>Preferred Stock</u>") as a bonus to the Recipient. The shares of Preferred Stock were offered and sold in reliance upon exemption from the registration requirements under Section 4(a)(2) under the Securities Act of 1933, as amended, and Rule 506(b) of Regulation D promulgated thereunder.

On August 28, 2024, the Company borrowed funds pursuant to the terms of a Securities Purchase Agreement (the "AJB SPA") entered into with AJB Capital Investments, LLC ("AJB"), and issued a Promissory Note in the principal amount of $120,000 (the "AJB Note") to AJB in a private transaction for a purchase price of $108,000, each dated as of August 28, 2024. In connection with the sale of the AJB Note, the Company also paid certain fees and expenses of AJB. After payment of the fees and expenses, the net proceeds to the Company were $98,000, which will be used for working capital, to fund potential acquisitions or other forms of strategic relationships, and other general corporate purposes.

The maturity date of the AJB Note is February 28, 2025. The AJB Note bears interest at a rate of twelve percent (12%) per calendar year from the date of issuance. The interest shall accrue on a monthly basis and is payable on the maturity date or upon acceleration or by prepayment or otherwise. The Company may prepay the AJB Note at any time without penalty. Under the terms of the AJB Note, the Company may not issue additional debt that is not subordinate to AJB, must comply with the Company's reporting requirements under the Securities Exchange Act of 1934, and must maintain the listing of the Company's common stock on the OTC Market or other exchange, among other restrictions and requirements. The Company's failure to make required payments under the AJB Note or to comply with any of these covenants, among other matters, would constitute an event of default. Upon an event of default under the AJB SPA or AJB Note, the AJB Note will bear interest at the lesser of 18% per annum or the maximum amount permitted under law, AJB may immediately accelerate the AJB Note due date, AJB may convert the amount outstanding under the AJB Note into shares of Company common stock at a discount to the market price of the stock, and AJB will be entitled to its costs of collection, among other penalties and remedies.

Effective June 28, 2024, the Company entered into stock agreements (each, a "Stock Agreement") with five separate recipients (each, a "Recipient"). Pursuant to the terms of the Stock Agreements, the Company issued a total of 910,770,639 shares of Company common stock as a bonus granted to certain Recipients who are employees and as a consideration for certain contractors' services for the Recipients who are contractors. Ronald Levy, Chief Executive Officer, Interim Chief Financial Officer, Chief Operating Officer, Chairman of the Board and Secretary of the Company, was one the Recipients. The shares of Company common stock were issued in a private transaction. The shares of Company common stock were offered and sold in reliance upon exemption from the registration requirements under Section 4(a)(2) under the Securities Act of 1933, as amended, and Rule 506(b) of Regulation D promulgated thereunder. Each of the Recipients had access to information about the Company or is a person to whom the Company believes the offer was exempt from registration.

On October 3, 2023, the Company entered into an Intellectual Property Assignment Agreement (the "IP Agreement") with AllFi Technologies, Inc., a Delaware corporation, and wholly owned subsidiary of the Company ("AllFi Technologies"), pursuant to which the Company assigns to AllFi Technologies: (i) a sublicense of code instance managed by TelBill, LLC under the Code Licensing Commerical Agreement dated as of August 29, 2023, by and between the Company and TelBill, LLC ("Code Licensing Commerical Agreement"), (ii) one runtime SaaS license for use by AllFi Technologies in the conduct of its coupon business for a term of 12 months in accordance with the Company's sublicense right under Section 2.1 of the Code Licensing Commerical Agreement in exchange for a fee to be mutually agreed to by the Company and AllFi Technologies through the use of such SaaS license, and (iii) one runtime SaaS license for use by AllFi Technologies in the conduct of its banking and marketplace business for a term of 12 months in accordance with the Company's sublicense right under Section 2.1 of the Code Licensing Commerical Agreement in exchange for a fee to be mutually agreed to by the Company and AllFi Technologies through the use of such SaaS license.

Also on October 3, 2023, the Company entered into a Subscription Agreement (the "Subscription Agreement") with AllFi Technologies, pursuant to which the Company agreed to purchase from AllFi Technologies an aggregate of 501 shares of AllFi Technologies' common stock, which represents 50.1% of the current issued and outstanding shares of AllFi Technologies, for a purchase price of $100,000. Upon the execution of the Subscription Agreement, the Company became a shareholder of AllFi Technologies.

In connection with the Company's investment in AllFi Technologies as described above, on October 7, 2023, the Company sold an aggregate of 22,104,583 shares of the Company's restricted common stock to AllFi Holdings LLC (the "Investor"), for a total purchase price of $1.00, pursuant to a Subscription Agreement by and between the Company and the Investor (the "Subscription Agreement").

On February 23, 2024, the Company entered into a License Agreement ("License Agreement") with AllFi Holdings LLC, a Wyoming limited liability company ("AllFi Holdings"), pursuant to which the Company grants to AllFi Holdings an exclusive license to utilize the Assigned IP (as defined in the License Agreement) associated with the utilization of the AllFi Brand. In consideration of the license granted under the License Agreement, AllFi Holdings will remit royalty payments to the Company for the utilization of the Assigned IP in accordance with the terms of the License Agreement.

On June 7, 2024, the Company completed the sale of AllFi Technologies, a majority owned subsidiary of the Company, to AllFi Holdings. AllFi Holdings purchased all of the issued and outstanding shares of common stock of the Company's subsidiary, AllFi Technologies. This sale was designed to optimize both companies' focus on their respective areas of expertise. As a result of this transaction, The Crypto Company received back from AllFi Holdings, its previously issued and committed shares, which totaled approximately 10% of The Crypto Company. In return, AllFi Holdings obtained full ownership of AllFi Technologies, including the trademarks and IP associated therewith.

*Voluntary Mutual Termination and Release Agreement*

On August 31, 2023, the Company entered into a Code Licensing Commercial Agreement (the "Code Licensing Agreement") with TelBill, LLC ("TelBill"), pursuant to which TelBill granted the Company a non-exclusive, worldwide, revocable, non-transferable, sublicensable, license to use and market its software and fin-tech products and services to the Company's customers. In exchange, the Company paid TelBill a sum of $300,000, paid in accordance with the fee schedule set forth in the Code Licensing Agreement. The Company also paid TelBill for all security system infrastructure costs and to manage the code instance, which were both be billed at actual cost with no markup. In addition, TelBill is entitled to share in the revenue generated by the Company through the use of TelBill's software, at a rate of 15% of net program profits. As additional consideration for the license, the Company provided TelBill with 19.98% equity in the Company in the form of warrants with a 30-year expiration, and which vest in accordance with the vesting schedule set forth in the Code Licensing Agreement.

The Agreement has a one hundred year term or will continue until it is terminated in accordance with the provisions set forth in the Code Licensing Agreement. Each party may terminate the Agreement, upon written notice to the other party. Neither party may assign the Agreement, including through a change of control. The Agreement also contains customary representations, warranties and covenants, and the parties have also agreed to indemnify and hold each other harmless from claims and losses arising directly or indirectly from the Agreement under certain circumstances.

On February 23, 2024, the Company entered into a Voluntary Mutual Termination and Release Agreement ("Termination Agreement") with TelBill, pursuant to which the Company and TelBill agreed to terminate the Code Licensing Commercial Agreement. The Company and TelBill have made customary representations, warranties, and covenants in the Termination Agreement.

In July 2025 the Company initiated a number of steps to implement a new cryptocurrency business strategy. In this regard, the Company borrowed funds from Three Mile Creek Future LLC ("TMCF") and issued a Promissory Note (the "Note") in the principal amount of 1.7 Bitcoin and a Pre-Funded Common Stock Purchase Warrant (the "Warrant"), which entitles TMCF to subscribe for and purchase from the Company up to 77,704,407 shares of the Company's common stock, each executed on July 16, 2025.

On July 22, 2025, the Company entered into a Consulting Agreement effective as of July 1, 2025, with Rafael Furst (the "Consultant") in connection with Consultant's appointment as the Company's Chief Strategy Officer (the "Consulting Agreement").

Under the terms of the Consulting Agreement, the Consultant will serve as an independent contractor and provide strategic advisory services to the Company, including advising on the implementation of the Company's crypto treasury strategy, blockchain education platform, M&A initiatives, and cross-platform product development over a three-month term, unless earlier terminated or extended by mutual written agreement of the parties. In consideration for the services, the Consultant will receive a total of $75,000 for the three-month term, payable on October 1, 2025, in cash or, at the Company's sole discretion, in fully vested shares of the Company's common stock at a 25% discount to the volume-weighted average price over the 10 trading days immediately preceding the payment date. The shares issued will be subject to restrictions under the Securities Act of 1933, as amended.

Either party may terminate the Consulting Agreement at any time prior to the expiration of the term by mutual written agreement. The Consulting Agreement will automatically terminate upon the execution of a definitive employment agreement between the Company and the Consultant.

***Comparison of the three months ended June 30, 2025 and June 30, 2024***

*Revenue*

Revenues for the three months ended June 30, 2025 and June 30, 2024, were $4,230 and $9,841, respectively. The decrease in revenue was due to less demand for blockchain training services due to advent of free artificial intelligence programs. Revenue for the 2025 period consisted of fees received for blockchain training and consulting generated by the Company's BTA subsidiary.

*General and Administrative Expenses*

For the three months ended June 30, 2025, our general and administrative expenses were $305,454 compared to $243,823 for the period ended June 30, 2024. The increase is primarily due to increased professional fees related to our new initiatives intended to increase revenue. There can be no assurance that these initiatives will be successful. General and administrative expenses consist primarily of costs relating to professional services, payroll, and payroll-related expenses. Professional services included in general and administrative expenses consist primarily of contracting fees, consulting fees, and accounting fees.

Share-based compensation was $469,764 and $439,487 for the three months ended June 30, 2025 and June 30, 2024, respectively.

*Other Income (Expense)*

During the three months ended June 30, 2025 other interest expense was $237,227 compared to other expense of $193,192 for the three months ended June 30, 2024. The increase is solely attributable to an increase in interest expense during the 2025 period related to higher levels of borrowing.

*Net Loss*

As a result of the foregoing we recorded a loss of $1,008,125 or $(0.00) per share for the three months ended June 30, 2025 compared to a loss of $874,395, or $(0.02) per share for the three month ended June 30, 2024.

***Comparison of the six months ended June 30, 2025 and June 30, 2024***

*Revenue*

Revenues for the six months ended June 30, 2025 and June 30, 2024, were $7,086 and $25,647 respectively. The decrease in revenue was due to less demand for blockchain training services due to advent of free artificial intelligence programs. Revenue for the 2025 period consisted of fees received for blockchain training and consulting generated by the Company's BTA subsidiary.

*General and Administrative Expenses*

For the six months ended June 30, 2025, our general and administrative expenses were $625,397 compared to $686,653 for the period ended June 30, 2024. The decrease is attributable to a reduction in activity at BTA offset by increased professional expenses during the six months ended June 30, 2025. General and administrative expenses consist primarily of costs relating to professional services, payroll, and payroll-related expenses. Professional services included in general and administrative expenses consist primarily of contracting fees, consulting fees, and accounting fees.

Share-based compensation was $628,473 and $1,706,700 for the six months ended June 30, 2025 and June 30, 2024, respectively.

*Other Income (Expense)*

During the six months ended June 30, 2025 other expense was $372,923 compared to other expense of $393,349 for the six months ended June 30, 2024. The slight decrease in the 2025 period is primarily attributable to a decrease in interest expense during the 2025 period.

*Net Loss*

As a result of the foregoing we recorded a loss of $1,619,708 or $(0.00) per share for the six months ended June 30, 2025 compared to a loss of $2,770,314, or $(0.09) per share for the six month ended June 30, 2024.

Liquidity

*Operating Activities*

Net cash used in operating activities was $295,436 for the six months ended June 30, 2025, compared to net cash used by operating activities of $601,739 for the six months ended June 30, 2024. The decrease in net cash used in operating activities during the 2025 period was primarily due to a reduction in net loss.

*Investing Activities*

Net cash used in investing activities was $0 and $0 for the six months ended June 30, 2025 and June 30, 2024.

*Financing Activities*

Net cash from financing activities for the six months ended June 30, 2025, was $297,951 compared to $560,155 for the six months ended June 30, 2024. The decrease in net cash from financing activities was primarily due to a reduction of promissory notes issued during the six months ended June 30, 2025 compared to the 2024 period.

**Trends, Events, and Uncertainties**

*Blockchain*

The blockchain technology market is dynamic and unpredictable. Although we will undertake compliance efforts, including efforts with commercially reasonable diligence, there can be no assurance that there will not be a new or unforeseen law, regulation or risk factor which will materially impact our ability to continue our business as currently operated or raise additional capital to foster our continued growth.

Other than as discussed in this Quarterly Report and our 2023 Annual Report, we are not aware of any other trends, events, or uncertainties that are likely to have a material effect on our financial condition.

*Critical Accounting Policies and Estimates*

The preparation of our consolidated financial statements requires us to make estimates that affect the reported amounts of assets, liabilities, revenue and expenses, and the related disclosure of contingent liabilities. We base our judgments on our historical experience and on various other assumptions that we believe are reasonable under the circumstances, the results of which form the basis for making estimates about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions. We have no material changes to our Critical Accounting Policies and Estimates disclosure as filed in our 2023 Annual Report.

*Recent Accounting Pronouncements*

See Note 3 to the consolidated financial statements for a discussion of recent accounting pronouncements.

*Off-Balance Sheet Transactions*

We do not have any off-balance sheet transactions.

**ITEM 3. Quantitative and Qualitative Disclosures About Market Risk.**

As a "smaller reporting company" as defined by Item 10 of Regulation S-K, the Company is not required to provide the information required by this Item.

**ITEM 4. Controls and Procedures.**

***Evaluation of Disclosure Controls and Procedures***

Our management, including our principal executive officer and principal financial officer, conducted an evaluation of the effectiveness of our disclosure controls and procedures, as defined in Rule 13a-15(e) or 15d-15(e) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), as of June 30, 2025. Based upon that evaluation, our principal executive officer and principal financial officer concluded that our disclosure controls and procedures were not effective as of June 30, 2025, to provide reasonable assurance that information we are required to disclose in reports that we file or submit under the Exchange Act is (i) recorded, processed, summarized and reported within the time periods specified in the SEC's rules and forms and (ii) accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosures. In designing and evaluating our disclosure controls and procedures, our management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their desired control objectives, and our management is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.

***Changes in Internal Control over Financial Reporting***

There have been no changes in our internal control over financial reporting during the period ended June 30, 2025, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

**PART II. Other Information**

**ITEM 1. Legal Proceedings.**

The Company is subject, from time to time, to various legal proceedings that are incidental to the conduct of its business. The Company is not involved in any pending legal proceeding that it believes would reasonably be expected to have a material adverse effect on its financial condition or results of operations.

**ITEM 1A. Risk Factors.**

In evaluating us and our common stock, we urge you to carefully consider the risks and other information in this Quarterly Report on Form 10-Q, the Risk Factors disclosed in Item 1A. of Part I of our Annual Report on Form 10-K for the fiscal year ended December 31, 2024, as well as additional risks and uncertainties not currently known to us or that we currently deem immaterial, that could materially and adversely affect our results of operations or financial condition.

**ITEM 3. Defaults upon Senior Securities.**

On April 24, 2023, the Company defaulted on the July 27, 2022 Coventry Note. The Company was in violation of covenants in the Coventry Note that require the Company to make the payment of any principal amount, guaranteed interest, or any other interest due under the Coventry Note, when due, subject to a five day cure period. Upon an event of default, consistent with the terms of the Coventry Note, the Coventry Note becomes convertible, in whole or in part, into shares of the Company's Common Stock at Coventry's option. On April 24, 2023, the Company received a notice of default in the amount of $17,916.94 of principal and $2,083.06 of interest. As per the terms of the Coventry Note, upon the occurrence and during the continuation of an event of default, the Coventry Note will become immediately due and payable. As of the filing date of this quarterly report on Form 10-Q, the total arrearage is $-0- since the Coventry Note has been paid in full.

**ITEM 4. Mine Safety Disclosures.**

Not applicable.

**ITEM 5. Other Information.**

During the six months ended June 30, 2025, no director or officer of the Company adopted or terminated a "Rule 10b5-1 trading arrangement" or "non-Rule 10b5-1 trading arrangement," as each term is defined in Item 408(a) of Regulation S-K.

On May 23, 2025, the Company issued a total of 83,603,144 shares of common stock, in lieu of cash to seven different consultants proving services to the Company.

On June 24, 2025 and June 25, 2025, the Company entered into stock agreement with five recipients to issue a total of 386,459,998 shares as a bonus to employees and contractors for services. Ronald Levy the Company's CEO received 197,605,773 of those Common Shares and Holly Ruxin, a director, received 67,106,721 of those Common Shares. The Common Shares received by Mr. Levy and Ms. Ruxin were on the same terms and conditions as the other Recipients.

**ITEM 6. Exhibits.**

---

| | |
|:---|:---|
| **Exhibit**<br> **Number** | **Document** |
| 10.1\* | [Stock Agreement dated as of June 25, 2025, by and between The Crypto Company and Leonid Sorin.](ex10-1.htm) |
| 10.2\* | [Stock Agreement dated as of June 25, 2025, by and between The Crypto Company and Rafael Furst.](ex10-2.htm) |
| 10.3\* | [Stock Agreement dated as of June 25, 2025, by and between The Crypto Company and Jared Strasser.](ex10-3.htm) |
| 10.4\* | [Stock Agreement dated as of June 24, 2025, by and between The Crypto Company and Ronald Levy.](ex10-4.htm) |
| 10.5\* | [Stock Agreement dated as of June 24, 2025, by and between The Crypto Company and Holly Ruxin.](ex10-5.htm) |
| 10.6\* | [Promissory Note, executed on June 30, 2025, by and between The Crypto Company and AJB Capital Investments LLC.](ex10-6.htm) |
| 10.7\* | [Securities Purchase Agreement, executed on June 30, 2025, by and between The Crypto Company and AJB Capital Investments LLC.](ex10-7.htm) |
| 10.8\* | [Security Agreement, executed on June 30, 2025, by and between The Crypto Company and AJB Capital Investments LLC.](ex10-8.htm) |
| 10.9 | [Promissory Note dated July 16, 2025 by and between The Crypto Company and Three Mile Creek Future LLC. (incorporated by reference to Exhibit 10.1 of the Company's Form 8-K filed on July 22, 2025).](https://www.sec.gov/Archives/edgar/data/1688126/000164117225020562/ex10-1.htm) |
| 10.10 | [Pre-Funded Common Stock Purchase Warrant dated July 16, 2025 by and between The Crypto Company and Three Mile Creek Future LLC (incorporated by reference to Exhibit 10.2 of the Company's Form 8-K filed on July 22, 2025).](https://www.sec.gov/Archives/edgar/data/1688126/000164117225020562/ex10-2.htm) |
| 10.11 | [Consulting Agreement dated July 22, 2025 by and between The Crypto Company and Rafael Furst. (incorporated by reference to Exhibit 10.3 of the Company's Form 8-K filed on July 22, 2025).](https://www.sec.gov/Archives/edgar/data/1688126/000164117225020562/ex10-3.htm)<br>|
| 10.12 | [Fifth Amendment to Promissory Note, executed on May 13, 2025, by and between the Crypto Company and AJB Capital Investments LLC (incorporated by reference to Exhibit 10.1 of the Company's Form 8-K as filed on May 19, 2025).](https://www.sec.gov/Archives/edgar/data/1688126/000164117225011446/ex10-1.htm) |
| 10.13 | [Pre-Funded Warrant issued to AJB Capital Investments LLC, executed on May 13, 2025 (incorporated by reference to Exhibit 10.2 of the Company's Form 8-K as filed on May 19, 2025).](https://www.sec.gov/Archives/edgar/data/1688126/000164117225011446/ex10-2.htm) |
| 31.1\* | [Certification of the Company's Principal Executive Officer, Principal Financial and Accounting Officer pursuant to Rule 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.](ex31-1.htm) |
| 32.1\*\* | [Certification of the Company's Principal Executive Officer, Principal Financial and Accounting Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.](ex32-1.htm) |
| 101.INS\* | Inline XBRL Instance Document |
| 101.SCH\* | Inline XBRL Taxonomy Extension Schema |
| 101.CAL\* | Inline XBRL Taxonomy Extension Calculation Linkbase |
| 101.DEF\* | Inline XBRL Taxonomy Extension Definitions Linkbase |
| 101.LAB\* | Inline XBRL Taxonomy Extension Label Linkbase |
| 101.PRE\* | Inline XBRL Taxonomy Extension Presentation Linkbase |
| 104\* | Cover Page Interactive Data File (embedded within the Inline XBRL document) |

---

\* Filed herewith.

\*\* Furnished, not filed.

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

---

| | | |
|:---|:---|:---|
| Dated: August 15, 2025 | **THE CRYPTO COMPANY** | **THE CRYPTO COMPANY** |
|  | (Registrant) | (Registrant) |
|  | By: | */s/ Ron Levy* |
|  |  | Ron Levy |
|  |  | Chief Executive Officer, Interim Chief Financial Officer,<br> Chief Operating Officer and Secretary<br> (Principal Executive Officer, Principal Financial<br> Officer and Principal Accounting Officer) |

---

## Exhibit 10.1

**Exhibit 10.1**

![](ex10-1_001.jpg)

![](ex10-1_002.jpg)

![](ex10-1_003.jpg)

![](ex10-1_004.jpg)

## Exhibit 10.2

**Exhibit 10.2**

![](ex10-2_001.jpg)

![](ex10-2_002.jpg)

![](ex10-2_003.jpg)

![](ex10-2_004.jpg)

## Exhibit 10.3

**Exhibit 10.3**

![](ex10-3_001.jpg)

![](ex10-3_002.jpg)

![](ex10-3_003.jpg)

![](ex10-3_004.jpg)

![](ex10-3_005.jpg)

## Exhibit 10.4

**Exhibit 10.4**

![](ex10-4_001.jpg)

![](ex10-4_002.jpg)

![](ex10-4_003.jpg)

![](ex10-4_004.jpg)

![](ex10-4_005.jpg)

## Exhibit 10.5

**Exhibit 10.5**

![](ex10-5_001.jpg)

![](ex10-5_002.jpg)

![](ex10-5_003.jpg)

![](ex10-5_004.jpg)

![](ex10-5_005.jpg)

## Exhibit 10.6

**Exhibit 10.6**

![](ex10-6_001.jpg)

![](ex10-6_002.jpg)

![](ex10-6_003.jpg)

![](ex10-6_004.jpg)

![](ex10-6_005.jpg)

![](ex10-6_006.jpg)

![](ex10-6_007.jpg)

![](ex10-6_008.jpg)

![](ex10-6_009.jpg)

![](ex10-6_010.jpg)

![](ex10-6_011.jpg)

![](ex10-6_012.jpg)

![](ex10-6_013.jpg)

![](ex10-6_014.jpg)

![](ex10-6_015.jpg)

![](ex10-6_016.jpg)

![](ex10-6_017.jpg)

![](ex10-6_018.jpg)

![](ex10-6_019.jpg)

![](ex10-6_020.jpg)

![](ex10-6_021.jpg)

![](ex10-6_022.jpg)

![](ex10-6_023.jpg)

![](ex10-6_024.jpg)

![](ex10-6_025.jpg)

## Exhibit 10.7

**Exhibit 10.7**

![](ex10-7_001.jpg)

![](ex10-7_002.jpg)

![](ex10-7_003.jpg)

![](ex10-7_004.jpg)

![](ex10-7_005.jpg)

![](ex10-7_006.jpg)

![](ex10-7_007.jpg)

![](ex10-7_008.jpg)

![](ex10-7_009.jpg)

![](ex10-7_010.jpg)

![](ex10-7_011.jpg)

![](ex10-7_012.jpg)

![](ex10-7_013.jpg)

![](ex10-7_014.jpg)

![](ex10-7_015.jpg)

![](ex10-7_016.jpg)

![](ex10-7_017.jpg)

![](ex10-7_018.jpg)

![](ex10-7_019.jpg)

![](ex10-7_020.jpg)

![](ex10-7_021.jpg)

![](ex10-7_022.jpg)

![](ex10-7_023.jpg)

![](ex10-7_024.jpg)

## Exhibit 10.8

**Exhibit 10.8**

![](ex10-8_001.jpg)

![](ex10-8_002.jpg)

![](ex10-8_003.jpg)

![](ex10-8_004.jpg)

![](ex10-8_005.jpg)

![](ex10-8_006.jpg)

![](ex10-8_007.jpg)

![](ex10-8_008.jpg)

![](ex10-8_009.jpg)

![](ex10-8_010.jpg)

![](ex10-8_011.jpg)

![](ex10-8_012.jpg)

![](ex10-8_013.jpg)

![](ex10-8_014.jpg)

![](ex10-8_015.jpg)

![](ex10-8_016.jpg)

![](ex10-8_017.jpg)

![](ex10-8_018.jpg)

## Exhibit 31.1

**Exhibit 31.1**

**CERTIFICATION PURSUANT TO**

**SECTION 302 OF THE SARBANES-OXLEY ACT**

I, Ron Levy, certify that:

1. I have reviewed this quarterly report on Form 10-Q for the quarter ended June 30, 2025, of The Crypto Company;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the period presented in this report;

4. I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to me by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c. evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d. disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal controls over financial reporting.

Date: August 15, 2025

---

| |
|:---|
| */s/ Ron Levy* |
| Ron Levy |
| Chief Executive Officer, Interim Chief Financial Officer,<br> Chief Operating Officer, and Secretary (Principal<br> Executive Officer and Principal Financial Officer) |

---

## Exhibit 32.1

**Exhibit 32.1**

**CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

In connection with the Quarterly Report of The Crypto Company (the "Company") on Form 10-Q for the quarter ended June 30, 2025 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Ron Levy, Chief Executive Officer, Interim Chief Financial Officer, Chief Operating Officer and Secretary of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that:

&nbsp;&nbsp;&nbsp;&nbsp;(1) The
 Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The
 information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of
 the Company.

IN WITNESS WHEREOF, the undersigned has executed this certification as of November 19, 2024.

---

| |
|:---|
| */s/ Ron Levy* |
| Ron Levy |
| Chief Executive Officer, Interim Chief Financial Officer,<br> Chief Operating Officer, and Secretary (Principal<br> Executive Officer and Principal Financial Officer) |

---

August 15, 2025